p39R861-4, A Type 2A/C2 Plasmid Carrying a Segment from the A/C1 Plasmid RA1

Sashindran Anantham1, Christopher J Harmer1, Ruth M Hall1

  • 1School of Molecular Bioscience, The University of Sydney , Sydney, Australia .

Microbial Drug Resistance (Larchmont, N.Y.)
|July 14, 2015
PubMed

Insights

The A/C2 plasmid p39R861-4, a plasmid size standard, was sequenced revealing a novel structure with an inverted backbone and two resistance islands. This detailed characterization enhances understanding of plasmid evolution and antimicrobial resistance.

Area of Science:

  • Microbiology
  • Genomics
  • Molecular Biology

Background:

  • Plasmid p39R861-4 is utilized as a size standard.
  • Previous reports identified it as the A/C1 plasmid RA1.

Purpose of the Study:

  • To determine the exact size and sequence of plasmid p39R861-4.
  • To elucidate the structural organization and genetic elements of p39R861-4.

Main Methods:

  • Conjugation to recover the plasmid.
  • Whole-genome sequencing to determine the complete nucleotide sequence.

Main Results:

  • Plasmid p39R861-4 is a 155,794-bp Type 2 A/C2 plasmid, not A/C1 RA1.
  • It contains a 39-kb segment from RA1 replacing part of the Type 2 backbone.
  • An 84-kb backbone segment is inverted due to recombination between inversely oriented CR2-sul2 regions.
  • Two resistance islands confer resistance to tetracycline (tetA(D)), sulfonamides (sul2), and florfenicol/chloramphenicol (floR).
  • The tet(D) determinant is within a Tntet(D) structure flanked by IS26.
  • Remnants of GIsul2 in resistance islands suggest sul2 mobilization by GIsul2.

Conclusions:

  • Plasmid p39R861-4 exhibits a unique mosaic structure with significant backbone inversion.
  • Its genetic makeup provides insights into the evolution of antimicrobial resistance genes and their mobilization.
  • The findings refine the characterization of plasmid standards and contribute to understanding plasmid diversity.